Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Pharmaceutical companies will continue to develop new drugs so long as Americans are willing to spend infinite money on them. If they can make a marginal profit on selling some to a European country, that's a nice bonus. If the US also implemented price controls, companies would have little incentive to fund the development of new drugs.


> If the US also implemented price controls, companies would have little incentive to fund the development of new drugs.

Your comment is correct except this sentence. In reality, if the US implemented price controls, it would simply reduce the negotiating power of European countries. Prices in the US would go down, and prices elsewhere would increase. The pharmaceutical profits would decrease on net, but there would still be plenty of incentive for R&D (much of which is already derisked by the massive amounts of public money spent on it with zero expectation of return).


Pharma is a terrible investment, they spend all money on R&D and acquisitions of firms that completed trials successfully

I don't know why people rail against Pharma when healthcare like hospitals have huge returns on investment in comparison.

https://www.morningstar.com/etfs/arcx/xph/performance

look how much pharma index trails healthcare


Whatever is the least "cozy" rhetorically, that is associated with good feelings, mother and apple pie style bullcrap, gets to be the designated scapegoat.


Offsetting R&D costs and directing R&D are a policy problem, and a completely different beast. The antibiotic resistance crisis is in front of us, yet the big returns are in cancer, with the additional wrinkle being that what is needed is new antibiotics of last resort. That's a problem of a kind that the market cannot solve.

Also: generic shortages. Generics are a low-margin business with maybe 6 suppliers workdwide. If one facility goes off-line for this or that reason there's going to be a shortage, and slack capacity is punished by the market. Right now the cisplatin shortage is in the news, and again the market is no help.


Generics may be a low-margin business for manufacturers, but they are emphatically not so for retailers. The likes of CVS make a lot of profit from generics, which makes it surprising that this hasn’t spurred pressure from on the manufacturers to amp up supply.


It's a constrained market - people aren't going to buy more cisplatin or cephalosporin just because it's cheaper. (Yes, people do shop around for a butt enlargement or Lasik but these things are strictly optional and can wait until the next month, however when you need a prescription drug you really need it.)




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: